p-MPPI hydrochloride

p-MPPI hydrochloride (CAS No.: 220643-77-6) is a synthetic small-molecule compound classified as a selective antagonist of the serotonin 5-HT1A receptor, widely utilized in neuropharmacology and central nervous system research to investigate serotonergic signaling pathways. Exhibiting high affinity for 5-HT1A receptors and the ability to penetrate the blood–brain barrier, p-MPPI hydrochloride functions by competitively inhibiting receptor activation, thereby modulating downstream signaling processes associated with mood, locomotor activity, and sleep–wake regulation. In preclinical models, it has been shown to counteract the behavioral and physiological effects induced by 5-HT1A receptor agonists, including alterations in REM sleep, locomotion, and characteristic serotonergic behavioral responses, while displaying minimal intrinsic behavioral effects when administered alone. Additionally, studies in rodent behavioral paradigms such as the elevated plus-maze demonstrate dose-dependent modulation of anxiety-related endpoints, supporting its utility as a pharmacological tool for dissecting receptor-specific contributions to affective and behavioral phenotypes. Its in vitro activity is generally characterized within nanomolar to low micromolar affinity ranges typical of high-affinity receptor antagonists, although precise values may vary depending on assay conditions. p-MPPI hydrochloride is commonly applied in receptor binding assays, functional cell-based studies, and in vivo animal models to explore serotonergic mechanisms, with experimental concentrations or dosing regimens determined by specific study designs and research objectives.